Do GLP-1 Medications Help Sleep Apnea?
August 26, 2026 · Arun Menon
Share
Last updated: August 2026 · Written by Arun Menon with the Reincarn Science Team
Quick answer
For one GLP-1 specifically, yes. Tirzepatide (Zepbound) is approved for moderate-to-severe obstructive sleep apnea in adults with obesity, after the SURMOUNT-OSA trial showed large reductions in apnea events, roughly 20 to 24 fewer breathing interruptions per hour, driven mainly by weight loss. Semaglutide (Ozempic, Wegovy) is not approved for sleep apnea. This works through weight loss, not sedation, and does not replace CPAP or medical care. Sleep apnea is a medical condition that needs professional diagnosis and treatment. This is general information, not medical advice.
One of the most striking developments in sleep medicine is that a weight-loss drug can meaningfully improve obstructive sleep apnea. But the details matter, which drug, for whom, and what it does not replace. Here is what the evidence actually shows.
Do GLP-1 medications help obstructive sleep apnea?
One does with strong evidence: tirzepatide is approved for moderate-to-severe obstructive sleep apnea in adults with obesity, based on large reductions in apnea events. In the SURMOUNT-OSA trials, tirzepatide reduced the apnea-hypopnea index by roughly 20 to 24 events per hour at one year, alongside significant weight loss, a large effect for OSA (Malhotra et al., 2024). This led to its approval for that use.
How does it work for sleep apnea?
Mainly through weight loss, which reduces the fat around the airway and the mechanical load that drives obstructive events, not through any sedative action. Obesity is a major driver of obstructive sleep apnea, so substantial weight loss can reduce airway collapse and breathing interruptions. The benefit is a downstream effect of weight change, not of the drug relaxing you to sleep. See how weight and sleep interact.
Does this apply to Ozempic and other GLP-1s?
The approval is specific to tirzepatide (Zepbound); semaglutide (Ozempic, Wegovy) is not approved for sleep apnea, even though weight loss on any drug may help in principle. Only tirzepatide has the OSA trial evidence and approval so far, so do not assume all GLP-1s are interchangeable for this use. Your doctor decides what is appropriate.
Does it replace CPAP or medical treatment?
No; it does not replace CPAP, medical diagnosis or care, and sleep apnea should always be assessed and managed by a professional. Sleep apnea is a serious medical condition, and any change to CPAP or treatment must be made by your doctor, not on your own. See a clinician for diagnosis and management.
What if you have not been diagnosed?
If you snore heavily, gasp or stop breathing in sleep, or wake unrefreshed with daytime sleepiness, ask a doctor about a sleep assessment. These can be signs of obstructive sleep apnea, which needs proper testing. A supplement does not diagnose or treat apnea. See why unrefreshing sleep is worth investigating.
What the research shows
| Point | What the evidence shows | Number |
|---|---|---|
| Tirzepatide for OSA | Reduced apnea events in obesity | ~20 to 24 fewer/hour (AHI) |
| Mechanism | Weight loss reduces airway load | Not sedation |
| Semaglutide for OSA | Not approved for this use | N/A |
| Replaces CPAP or care | No; medical management still required | Consult a doctor |
For everyday sleep quality, not a treatment for apnea
REINCARN Night Reboot is a melatonin-free food supplement for general everyday sleep support. It is not a medicine and not a treatment for sleep apnea, which needs medical diagnosis and care. If you have or suspect sleep apnea, or take prescription medication, speak with your doctor. For adults 18 and over.
Join the waitlistFrequently asked questions
Do GLP-1 medications help sleep apnea?
Tirzepatide (Zepbound) is approved for moderate-to-severe obstructive sleep apnea in adults with obesity, after trials showed large reductions in apnea events driven by weight loss. Semaglutide is not approved for this use.
How does tirzepatide help sleep apnea?
Mainly through weight loss, which reduces the fat around the airway and the mechanical load causing obstructive events, not through sedation.
Can Ozempic treat sleep apnea?
Ozempic (semaglutide) is not approved for sleep apnea. Only tirzepatide currently has the trial evidence and approval for this use.
Does a GLP-1 replace CPAP?
No. It does not replace CPAP or medical care. Sleep apnea is a medical condition that must be diagnosed and managed by a doctor.
The bottom line. A GLP-1 helping sleep apnea is real, but specific: tirzepatide, in obesity, through weight loss, with large measured reductions in breathing interruptions, and it does not replace CPAP or medical care. If you have or suspect sleep apnea, that is a conversation for a doctor, not a supplement. So the honest takeaway is that the science is genuinely exciting, and it belongs firmly in medical hands.
Written by the Reincarn Science Team. Authored by Arun Menon, founder of REINCARN and a researcher in sleep science and nutraceutical formulation, translating peer-reviewed research into evidence-based guidance with the Reincarn Science Team at Zandra Life Sciences.
References
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205. PMID 38912654.
- Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med. 2010;153(7):435-441. PMID 20921542.
Not medical advice. This article is for general information only and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change any prescription medication or supplement without consulting the doctor who prescribed it. Obstructive sleep apnea is a serious medical condition requiring professional diagnosis and treatment; REINCARN Night Reboot is not a treatment for sleep apnea. REINCARN Night Reboot is a food supplement for general sleep support, not a medicine, and is not intended to diagnose, treat, cure or prevent any disease or any medication side effect. For adults 18 and over; not for use in pregnancy or breastfeeding.
Publisher disclosure. Published by REINCARN (Zandra Life Sciences Pvt. Ltd.). Regulated as a food supplement by the FSSAI. Corrections: reincarn@zandralifesciences.com.